AssayIndex
SWB cross-section

SWB by compound

SWB records split by compound, with the index-wide comparison for the same compound beside each one. 27 compounds, 317 records. Cells below n=3 print their raw values instead of a median.

27 compounds317 records
CompoundClassReportsSWB median %Index median %Δ (pp)SpecPass %
SemaglutideIncretin4798.6698.87-0.2197.0100
Melanotan IIMelanocortin-receptor3899.4699.24+0.2298.597
RetatrutideIncretin2298.4898.41+0.0896.5100
BPC-157Tissue-repair2199.3699.15+0.2198.0100
TirzepatideIncretin1698.6398.44+0.1997.088
IGF-1 LR3Growth-hormone1597.1397.75-0.6295.0100
IGF-1 DES (1-3)Growth-hormone1497.9498.53-0.5995.0100
NAD+Non-peptide1298.9798.88+0.0997.0100
MGFGrowth-hormone1298.4198.73-0.3297.5100
SelankNeuroactive1299.1599.13+0.0199.075
5-Amino-1MQNon-peptide1299.2899.24+0.0498.0100
IpamorelinGrowth-hormone1299.8599.48+0.3799.0100
Kisspeptin-10Melanocortin-receptor1098.5699.27-0.7098.560
L-Glutathione (reduced)Short1098.7899.00-0.2198.590
Thymosin α1Tissue-repair999.3099.11+0.1997.5100
AOD-9604Metabolic999.1499.25-0.1198.0100
MazdutideIncretin898.2798.11+0.1696.5100
N-Acetyl Semax AmideNeuroactive7 n=799.5099.26+0.2498.5100
PT-141 (Bremelanotide)Melanocortin-receptor7 n=799.1099.31-0.2298.5100
CJC-1295 with DACGrowth-hormone5 n=598.5698.79-0.2397.5100
GonadorelinHypothalamic5 n=598.6299.28-0.6698.580
P21Neuroactive4 n=499.1999.190.0098.0100
MK-677 (Ibutamoren mesylate)Non-peptide3 n=399.3299.37-0.0598.5100
ExenatideIncretin2 n=2n<398.9498.0100
CJC-1295 (no DAC)Growth-hormone2 n=2n<398.6198.0100
Enclomiphene citrateNon-peptide2 n=2n<399.2398.5100
CagrilintideIncretin1 n=1n<398.5996.5100
95.896.597.298.098.799.5100.2SemaglutideSemaglutide: Q1 98.22, median 98.66, Q3 99.32, n=47n=47Melanotan IIMelanotan II: Q1 99.18, median 99.46, Q3 99.80, n=38outlier 98.25n=38RetatrutideRetatrutide: Q1 98.17, median 98.48, Q3 99.00, n=22n=22BPC-157BPC-157: Q1 98.73, median 99.36, Q3 99.71, n=21n=21TirzepatideTirzepatide: Q1 97.75, median 98.63, Q3 99.27, n=16n=16IGF-1 LR3IGF-1 LR3: Q1 96.93, median 97.13, Q3 97.35, n=15outlier 96.06outlier 98.19outlier 98.31outlier 98.43n=15IGF-1 DES (1-3)IGF-1 DES (1-3): Q1 97.73, median 97.94, Q3 98.23, n=14n=14NAD+NAD+: Q1 98.79, median 98.97, Q3 99.18, n=12n=12MGFMGF: Q1 98.36, median 98.41, Q3 98.89, n=12n=12SelankSelank: Q1 99.07, median 99.15, Q3 99.35, n=12outlier 99.93n=125-Amino-1MQ5-Amino-1MQ: Q1 99.06, median 99.28, Q3 99.60, n=12n=12IpamorelinIpamorelin: Q1 99.47, median 99.85, Q3 99.91, n=12n=12Kisspeptin-10Kisspeptin-10: Q1 98.38, median 98.56, Q3 98.94, n=10n=10L-Glutathione (reduce…L-Glutathione (reduce…: Q1 98.70, median 98.78, Q3 98.94, n=10outlier 98.18outlier 99.79n=10 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.